A privately held drug design company pairing generative AI with biophysics simulation to move hard targets from a single hit to lead stage.
YDS Pharmatech, Inc.
Released September 30, 2024
Chemical language model that grows molecules one fragment at a time from one or two input fragments, for hit-to-lead design and PROTAC linkers.